MedicalResearch.com Interview with:
[caption id="attachment_61313" align="alignleft" width="150"]
Prof. Tanaka[/caption]
Takemi Tanaka, Ph. D.
Professor, Stephenson Cancer Center
Department of Pathology, School of Medicine
University of Oklahoma Health Science Center
MedicalResearch.com: What is the background for this study?
Response: Our previous cohort study has shown that breast cancer progresses 60 days after diagnostic biopsy in early-stage ER+ breast cancer. Others have also reported increased breast cancer mortality due to surgery delay. These observations raised the question of how slow-growing ER+ breast cancer progresses so quickly in just 60 days following diagnosis, prompting us to hypothesize whether needle biopsy of breast tumors accelerates pro-metastatic changes.
